Overview

Safety and Efficacy Study of Ftortiazinon in the Treatment of Patients With Complicated Urinary Tract Infections Caused by P. Aeruginosa

Status:
Recruiting

Trial end date:
2022-01-31

Target enrollment:

Participant gender:

Summary

This study is planned to evaluate the safety and efficacy of the drug Ftortiazinon in combination with the drug Maxipime® in comparison with placebo in combination with the drug Maxipime® in the treatment of hospitalized adult patients with complicated urinary tract infections caused by P. aeruginosa.

Phase:

Phase 2

Details

Lead Sponsor:

Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation

Collaborators:

Accellena Research and Development
Acellena Contract Drug Research and Development

Treatments:

Cefepime